Media Coverage


March 28, 2017 – AdvaMed Statement on House Medical Device User Fee Hearing

AdvaMed “The Advanced Medical Technology Association (AdvaMed) issued the following statement from President and CEO Scott Whitaker on today’s hearing in the House Energy and Commerce Health Subcommittee on reauthorization of the Medical Device User Fee Act (MDUFA)”


March 28, 2017 – Examining FDA’s Medical Device User Fee Program

The Energy and Commerce Committee “Hear Cohera Medical’s President and CEO, Patrick Daly, speak to the House Energy and Commerce Health Subcommittee on the Medical Device User Fee Act at timestamp 2:06:33.”


January 4, 2017 – Cohera Medical starts off strong in 2017, enrolls first patient in Sylys trial

Medical Device Daily “FDA launched its new Expedited Access Pathway in April, and Cohera Medical is now the first company to announce participation for its Sylys Surgical Sealant. Under the program, Cohera hopes to use an interim trial analysis to accelerate the product’s path to market.”


June 19, 2015 – Cohera Medical’s Novel Sealant Picked for FDA ‘Expedited Access

The Gray Sheet logoThe Gray Sheet “FDA launched its new Expedited Access Pathway in April, and Cohera Medical is now the first company to announce participation for its Sylys Surgical Sealant.

April 29, 2015 – First Surgical Glue Approved for Use Inside the Body

Voice of America “The first biodegradable surgical glue for internal use has won approval from the U.S. Food and Drug Administration.”

February 6, 2015 – Drainless Tummy Tucks Now Possible: FDA Approves Cohera Medical’s TissuGlu

Plastic Surgery Practice logoPlastic Surgery Practice “The US Food and Drug Administration (FDA) has green-lighted Cohera Medical’s TissuGlu, the first tissue adhesive for internal use.

TissuGlu is a urethane-based adhesive that a surgeon can use to connect tissue flaps made during abdominoplasty surgery. Connecting the tissue flaps with an internal adhesive may reduce or eliminate the need for postoperative surgical draining of fluid between the abdominoplasty tissue flaps.”


February 5, 2015 – FDA approves first tissue glue for internal body use

Philadelphia Inquirer logoPhiladelphia Inquirer “The U.S. Food and Drug Administration on Wednesday approved the first tissue adhesive for internal use in the body, giving a big boost to the Pittsburgh company that has spent eight years developing its first product.”


February 4, 2015 – First Synthetic Adhesive For Internal Use Gets FDA Approval

RTT News logoRTT News “Fuelled by technological advancements and innovations, the demand for improved medical adhesives and sealants for surgical procedures has been on the rise. The global medical adhesives and sealants market was valued at $6.39 billion in 2013 and is expected to reach $11.75 billion by 2020, according to a market report published by Transparency Market Research.”


August 20, 2014 – Surgical Adhesive Technology Receives FDA Panel Recommendation

McGowan Institute logoMcGowan Institute of Regenerative Medicine “Several years ago, McGowan Institute for Regenerative Medicine faculty member Eric Beckman, PhD, George M. Bevier Professor of Engineering in the University of Pittsburgh Department of Chemical and Petroleum Engineering, and Michael Buckley, MD, oral and maxillofacial surgeon, invented a novel medical adhesive technology. The new adhesive—now known as TissuGlu®—was designed to meet a market demand for a strong, safe tissue adhesive to improve the wound closure process.”


August 18, 2014 – Cohera Medical on the cusp of FDA approval for its first surgical adhesive

NEXT Pittsburgh logoNEXT Pittsburgh “This month the FDA General and Plastic Surgery Devices Panel voted unanimously on the safety, efficacy and benefits of the surgical adhesive, paving the way for final FDA approval.”


August 6, 2014 – Cohera Ponders TissuGlu Launch Plans Post Panel

The Gray Sheet logoThe Gray Sheet “Cohera Medical is looking toward a potential first-quater 2015 launch of its novel TissuGlu surgical adhesive for large-flap procedures following close votes in the product’s favor from an FDA panel on Aug.1.”


August 4, 2014 – FDA panel recommends TissuGlu surgical adhesive, says it is effective in 6-5 vote

Fierce Medical Devices logoFierce Medical Devices “Cohera Medical’s TissuGlu surgical adhesive took another step towards securing PMA approval from the FDA, following the narrow recommendation of the agency’s General and Plastic Surgery Advisory on Aug. 1.”

August 4, 2014 – Cohera gains FDA panel support for surgical adhesive [Newsletter]

Advamed SmartBrief logoAdvaMed SmartBrief “A panel of FDA advisers has agreed to endorse approval for Cohera Medical’s TissuGlu surgical adhesive, saying the technology is effective and safe and that its benefits are greater than its risks.”


August 2, 2014 – Drainless Tummy Tucks Edge Closer to Reality

Plastic Surgery Practice logoPlastic Surgery Practice “Cohera Medical, Inc.®‘s TissuGlu® should be approved for use in large flap surgeries such as abdominoplasties, according to a US Food and Drug Administration advisory panel.”


February 27, 2014 – Glues promise to cut the need for stitches “One of the latest adhesives for use in the body, TissuGlu, aims to eliminate the need for fluid drains after reconstructive surgeries such as tummy tucks or mastectomies.“


January 22, 2014 – Cohera Medical Raises $26.3M in Series D Funding Round

MD+DI logoMD+DI “Cohera Medical, a developer of in-body surgical adhesives and sealants has raised additional money to close its Series D financing round at $26.3 million.”

January 8, 2014 – Surgical Glue to Mend Broken Hearts

MIT Technology Review logoTechnology Review “Beckman’s company, Cohera Medical of Pittsburgh, has a product on the market in Europe designed to seal large areas of tissue after mastectomies and tummy tucks, eliminating the need to implant painful drains.”